We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cell Spray Technology Could Help Treat Severe Wounds

By HospiMedica International staff writers
Posted on 05 Oct 2016
A quick-healing spray system uses a patient’s own stem cells as an alternative to conventional skin graft surgery, which can be painful, prone to complications, and slow-to-heal.

The CellMist System is an innovative investigational treatment for processing and spraying a patient’s own stem cells onto wounds for rapid healing. More...
The system is comprised of the CellMist Solution, a liquid suspension containing a patient’s own stem cells which are isolated from a small sample of their skin, using a patented extraction process. The second component of the system is the SkinGun device, which gently sprays the CellMist Solution on to a wound site for rapid healing. Once sprayed onto the wound site, the patient’s stem cells go to work, naturally and rapidly regenerating damaged skin.

Patented SkinGun technology results in 200-times more droplets formed than in conventional syringe deposition; for example, in an 8 cm diameter surface area, the SkinGun can deliver more than 20,000 evenly distributed droplets, versus only 91 droplets by conventional needle and syringe methods. The CellMist System is designed to replace traditional skin grafts, requiring only a postage stamp-sized sample of donor skin, which can be processed within 90 minutes of arriving in an emergency room. The CellMist System is under development by RenovaCare (New York, NY, USA).

“The prospect of spraying a patient’s own stem cells onto burns and wounds to create rapid, scar-free healing is a promising alternative to today’s painful and disfiguring skin grafting procedures,” said Thomas Bold, President and CEO of RenovaCare. “For patients, we are working towards natural, rapid healing where their new skin can look and function as well as it once did. For surgeons, it’s a relief to no longer have to remove vast sheets of healthy skin and surgically stitch it to wound sites.”

Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, etc). They have been successfully used for many years to treat leukemia and related bone cancers through bone marrow transplants. Adult somatic stem cells can now be artificially grown and differentiated into specialized cell types with characteristics consistent with cells of various tissues.

Related Links:
RenovaCare



Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Patient Monitoring System
AlarmSense
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.